The Cancer Prevention and Research Institute of Texas (CPRIT) is honoring the legacy of Carson Leslie and the Carson Leslie Foundation by naming one of the conference rooms in CPRIT’s new office in the William B. Travis State Office...
We didn’t raise all that moola; But right in the middle of DIRECTING it! “..it’s important for Texas to remain a national leader in cancer research & prevention..” American Cancer Society (ACS) Individual Investigator Awards for Cancer in Children...
CPRIT Opens RFA For Individual Investigator Research Awards Targeting Childhood, Adolescent Cancer Researchers While cancer research is no doubt a heavily funded endeavor, the amount of funding, research, and commercial development is heavily weighted toward the treatment of adults...
Carson Leslie Awards for Pediatric Brain Cancers provides over $3,200,000.00 for Childhood Brain cancer Research – Carson Leslie Awards for Pediatric Brain Cancers, a partnership between The Carson Leslie Foundation (CLF) and The Cancer Prevention and Research Institute of...
My boy lived his whole-short life in Dallas. With his confident swagger and a smile that would warm a room Carson captivated the hearts of many Dallasites including Emmitt Smith, Roger Staubach, Jessica Simpson, Michael Young, Jerry Jones and...
The Carson Leslie Foundation 16250 Knoll Trail Drive #102 Dallas, TX 75248 (214) 417-2155 carrymecarson@gmail.com www.carsonlesliefoundation.org FOR IMMEDIATE RELEASE – January 6, 2013 The Cancer Prevention and Research Institute of Texas (CPRIT) is at it again; Funding prevention and...
CPRIT has been notified by Governor Perry, Lt. Governor Dewhurst and Speaker Straus that the moratorium on CPRIT’s grant award processes has been lifted. Over the last ten months CPRIT has taken purposeful strides to strengthen agency governance and...
We are so excited to announce that after 2 years of persistence and hard work, last week, the Creating Hope Act was passed by the House of Representatives AND last night, the Senate passed the Creating Hope Act as...
